CRISPR specialist Akribion Therapeutics, a 2024 spin-off from BRAIN Biotech, raised €8M in seed funding led by CARMA FUND and RV Invest. The funds will support...
Brain Biotech shares surged 85%, fueled by news of a major deal with Royalty Pharma. However, the contract's full value, €128.88 million, is conditional on meeting...